Dipyrone for acute primary headaches

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 7, 2014, Pages

  Ramacciotti, Adriana S ^a   Soares, Bernardo G O ^b   Atallah, Álvaro N ^c   Hobson, Anna ^d  

^a Brazilian Cochrane Centre   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Brazilian Cochrane Center   (Brazil)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRIORITY JOURNAL; RETRACTED ARTICLE; REVIEW; ACUTE DISEASE; ADULT; HEADACHE DISORDERS, PRIMARY; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANALGESIC AGENT; DIPYRONE;

ACUTE DISEASE; ADULT; ANALGESICS, NON-NARCOTIC; DIPYRONE; HEADACHE DISORDERS, PRIMARY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84922395192     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004842.pub3     Document Type: Review

References (29)

1. Bigal ME, Bordini CA, Speciali JG. Intravenous dipyrone for the acute treatment of episodic tension-type headache: a randomized, placebo-controlled, double-blind study. Brazilian Journal of Medical & Biological Research 2002;35(10):1139-45.
2. Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study. Headache 2002;42(9):862-71.
3. Bigal ME, Bordini CA, Speciali JG. Efficacy of three drugs in the treatment of migrainous aura: a randomized placebo-controlled study [Eficácia de três drogas sobre a aura migranosa: um estudo randomizado placebo controlado]. Arquivos de Neuro-Psiquiatria 2002;60(2-B):406-9.
4. Martinez-Martin P, Raffaelli E Jr, Titus F, Despuig J, Fragoso YD, Diez-Tejedor E, et al. Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia 2001;21(5):604-10.
5. Bigal ME, Bordini CA, Speciali JG. Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache--a placebo-controlled study. Cephalalgia 2001;21(2):90-5.
6. Hackenthal E. Paracetamol and metamizol in the treatment of chronic pain syndromes [Paracetamol and Metamizol in der Therapie chronischer Schmerzen]. Schmerz 1997;11(4):269-75.
7. Lujan M, Lopez-Fiesco A, Lopez y Martinez E, Zamora Lopez G, Alvarez Rueda M. Experimental tension headache in humans: a double blind comparison of the analgesic effect of dipyrone, naproxen plus paracetamol or placebo. Proceedings of the Western Pharmacology Society 1992;35:201-5.
8. Classen W. Placebo application, personality, and headaches: a signal detection theory analysis of experimentally induced pain in comparison to clinical pain. Pharmacopsychiatry 1984;17(3):98-101.
9. Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA 1962;179(9):717-8.
10. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313(7066):1200.
11. Bäckström M, Hägg S, Mjörndal T, Dahlqvist R. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis. Pharmacoepidemiology and Drug Safety 2002;11(3):239-45.
12. Edwards JE, Meseguer F, Faura CC, Moore RA, McQuay HJ. Single dose dipyrone for acute postoperative pain. Cochrane Database of Systematic Reviews 2001, Issue 1. [Art. No.: CD003227. DOI: 10.1002/14651858.CD003227]
13. Edwards JE, Meseguer F, Faura C, Moore RA, McQuay HJ. Single dose dipyrone for acute renal colic pain. Cochrane Database of Systematic Reviews 2002, Issue 4. [Art. No.: CD003867. DOI: 10.1002/14651858.CD003867]
14. Edwards JE, McQuay HJ. Dipyrone and agranulocytosis: what is the risk?. Lancet 2002;360(9344):1438.
15. Fendrich Z. Metamizol - a new effective analgesic with a long history. Overview of its pharmacology and clinical use [Metamizol - nové úcinné analgetikum s dlouhou historií. Prehled farmakologie a praktického vyuzití]. Casopis Lekaru Ceskych 2000;139(14):440-4.
16. Finkel AG. Epidemiology of cluster headache. Current Pain & Headache Reports 2003;7(2):144-9.
17. Hamerschlak N, Maluf E, Pasquini R, Eluf-Neto J, Moreira FR, Cavalcanti AB, et al. Incidence of aplastic anemia and agranulocytosis in Latin America--the LATIN study. Sao Paulo Medical Journal = Revista Paulista de Medicina 2005;123(3):101-4. [ISSN 1516-3180]
18. Higgins JPT, Green S, editors. Selection bias. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 6.3. http://www.cochrane.org/resources/handbook/hbook.htm (accessed 24th July 2006).
19. Higgins JPT, Green S, editors. Intention-to-treat issues. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 8.4. http://www.cochrane.org/resources/handbook/hbook.htm (accessed 24th July 2006).
20. The International Agranulocytosis and Aplastic Anemia Study. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 1986;256(13):1749-57.
21. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96.
22. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
23. Lipton RB, Stewart WF, Von KorffM. The burden of migraine. A review of cost to society. Pharmacoeconomics 1994;6(3):215-21.
24. McQuay H, Moore R. An evidence-based resource for pain relief. Oxford: Oxford University Press, 1998.
25. Pryse-Phillips W, Findlay H, Tugwell P, Edmeads J, Murray TJ, Nelson RF. A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Canadian Journal of Neurological Sciences 1992;19(3):333-9.
26. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA 1998;279(5):381-3.
27. Scott J, Huskisson EC. Graphic representation of pain. Pain 1976;2(2):175-84.
28. Solomon GD, Price KL. Burden of migraine. A review of its socioeconomic impact. Pharmacoeconomics 1997;11 Suppl 1:1-10.
29. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992;267(1):64-9.